Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0144 | 0.6261 | 0.6456 |
Echinococcus granulosus | geminin | 0.0205 | 0.9698 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.3935 | 0.3935 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0066 | 0.1923 | 0.1982 |
Schistosoma mansoni | tar DNA-binding protein | 0.0195 | 0.9181 | 0.9467 |
Brugia malayi | hypothetical protein | 0.0102 | 0.3935 | 0.3935 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0144 | 0.6261 | 0.6261 |
Echinococcus granulosus | GPCR family 2 | 0.0066 | 0.1923 | 0.1982 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 0.5067 | 0.5067 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0066 | 0.1923 | 0.1982 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.9698 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0195 | 0.9181 | 0.9467 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.1923 | 0.1982 |
Brugia malayi | hypothetical protein | 0.0066 | 0.1897 | 0.1897 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.9698 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0066 | 0.1923 | 0.1982 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0102 | 0.3935 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0066 | 0.1923 | 0.1982 |
Loa Loa (eye worm) | TAR-binding protein | 0.0195 | 0.9181 | 0.9181 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0046 | 0.0763 | 0.0787 |
Loa Loa (eye worm) | hypothetical protein | 0.021 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0195 | 0.9181 | 0.9181 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.1923 | 0.1982 |
Echinococcus multilocularis | GPCR, family 2 | 0.0066 | 0.1923 | 0.1982 |
Brugia malayi | TAR-binding protein | 0.0195 | 0.9181 | 0.9181 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0102 | 0.3935 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0102 | 0.3935 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0195 | 0.9181 | 0.9467 |
Brugia malayi | MH2 domain containing protein | 0.0122 | 0.5067 | 0.5067 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 0.5067 | 0.5067 |
Loa Loa (eye worm) | RNA binding protein | 0.0195 | 0.9181 | 0.9181 |
Echinococcus multilocularis | geminin | 0.0205 | 0.9698 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0102 | 0.3935 | 1 |
Brugia malayi | RNA binding protein | 0.0195 | 0.9181 | 0.9181 |
Schistosoma mansoni | tar DNA-binding protein | 0.0195 | 0.9181 | 0.9467 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.1923 | 0.1923 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0102 | 0.3935 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0102 | 0.3935 | 1 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0097 | 0.3637 | 0.3637 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0102 | 0.3935 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0066 | 0.1923 | 0.1923 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.0763 | 0.0787 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0066 | 0.1923 | 0.1923 |
Schistosoma mansoni | tar DNA-binding protein | 0.0195 | 0.9181 | 0.9467 |
Echinococcus multilocularis | tar DNA binding protein | 0.0195 | 0.9181 | 0.9467 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0102 | 0.3935 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor | 0.0092 | 0.3346 | 0.3346 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.6261 | 0.6261 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.1923 | 0.1982 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.3377 | 0.3377 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0195 | 0.9181 | 0.9181 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.1923 | 0.1982 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0097 | 0.3637 | 0.3751 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0046 | 0.0763 | 0.0787 |
Schistosoma mansoni | tar DNA-binding protein | 0.0195 | 0.9181 | 0.9467 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.021 | 1 | 1 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0097 | 0.3637 | 0.3751 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0032 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.021 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0066 | 0.1923 | 0.1923 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.